Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Chemotherapy and Pharmacology
Published in: Cancer Chemotherapy and Pharmacology 2/2015

01-02-2015 | Original Article

Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague–Dawley rats

Authors: Kuppusamy Periyasamy, Kuppusamy Baskaran, Aruldass Ilakkia, Kalappan Vanitha, Sundaramoorthy Selvaraj, Dhanapal Sakthisekaran

Published in: Cancer Chemotherapy and Pharmacology | Issue 2/2015

Login to get access

Abstract

Purpose

The aim of the present study was to assess the chemopreventive and chemotherapeutic efficacy of tangeretin on DMBA-induced oxidative stress in breast cancer-bearing Sprague–Dawley rats.

Methods

In this study, the experimental animals were divided into five groups of six animals each. Group I was control, Group II was DMBA-induced breast cancer-bearing rats, Group III was tangeretin pre-treated (50 mg/kg body weight for 30 days orally) breast cancer-bearing animals, Group IV was tangeretin post-treated (50 mg/kg body weight for 30 days orally) and Group V was tangeretin (50 mg/kg body weight) alone treated animals.

Results

We have observed the general characteristics of cancer, oxidative stress markers, breast cancer marker, antioxidants and histopathological changes in the experimental animals. We have recorded the body weight, tumor weights, tumor volume and antitumor activity of tangeretin in the experimental animals. Oxidative stress markers, like NO and LPO, and breast cancer marker CEA levels were significantly (p < 0.001, p < 0.05) increased as well as the antioxidants like SOD, CAT, GPx, GST, GSH, ascorbic acid and α-tocopherol were found to be significantly (p < 0.05) decreased in cancer-bearing Group II animals. Whereas, the enzymic and non-enzymic antioxidant levels were found to be significantly decreased in cancer-bearing animals. However, in tangeretin pre-treated and post- treated animals, the levels of antioxidants and breast cancer marker were found to be significantly (p < 0.05) reduced with a concomitant increase in the activities of the antioxidants (p < 0.05). In tangeretin alone treated Group V animals, no significant changes were observed in the levels of antioxidants and breast cancer marker. These results were adequately supported by the histopathological studies in the mammary tissues of the experimental animals.

Conclusion

From this study, we conclude that the administration of tangeretin was found to be beneficial against DMBA-induced oxidative stress in breast cancer-bearing animals. Hence, we strongly suggest that tangeretin is effective and efficient candidate for the treatment of experimental breast cancer.
Literature
1.
Kosenko E, Kaminsky Y, Lopata O, Muravyov N, Kaminsky A, Hermenegildo C, Stavroskaya IG, Felipo V (1998) Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication. Metab Brain Dis 13:29–41PubMedCrossRef
2.
Schliess F, Gorg B, Fischer R, Desjardins P, Bidmon HJ, Herrmann A, Butterworth RF, Zilles K, Haussinger D (2002) Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine and residues in rat astrocytes. FASEB J 16:739–741PubMed
3.
Fenton HJH (1894) Oxidation of tartaric acid in presence of iron. J Chem Soc Trans 65:899–911CrossRef
4.
Ioannides C (2002) Enzyme systems that metabolise drugs and other xenobiotics. Wiley, New York
5.
Albertson DG, Collins C, McCormick F, Gray JW (2003) Chromosome aberrations in solid tumors. Nat Genet 34:369–376PubMedCrossRef
6.
Baylin SB, Herman JG (2000) DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16:168–174PubMedCrossRef
7.
Ekambaram G, Rajendran P, Magesh V, Sakthisekaran D (2008) Naringenin reduces tumor size and weight lost in N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res 28(2):106–112PubMedCrossRef
8.
Mukhtar H, Ahmad N (1999) Cancer chemoprevention: future holds in multiple agents. Toxicol Appl Pharmacol 158(3):207–210PubMedCrossRef
9.
Krishnan K, Ruffin MT IV, Brenner DE (1998) Cancer chemoprevention. A new way to treat cancer before it happens. Prim Care 25(2):361–379PubMedCrossRef
10.
Ding M, Yongju L, Bowman L, Huang C, Leonard S, Wang L, Vallyathan V, Castranova V, Shi X (2004) Inhibition of AP-1 and neoplastic transformation by fresh apple peel extract. J Biol Chem 279:10670–10676PubMedCrossRef
11.
Nelson EK (1934) The occurrence of a pentamethyl flavonol in tangerine peel. J Am Chem Soc 56:1392–1393CrossRef
12.
Pan Min-Hsiung, Chen Wei-Jen, Lin-Shiau Shoei-Yn, Ho Chi-Tang, Lin Jen-Kun (2002) Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 23(10):1677–1684PubMedCrossRef
13.
Yao X, Xu X, Fan G, Qiao Y, Cao S, Pan S (2009) Determination of synergistic effects of polymethoxylated flavones extracts of Jinchen orange peels (Citrus Sinensis Osberk) with amino acids and organic acids using chemiluminescence. Eur Food Res Technol 229:743–750CrossRef
14.
Lowry O, Rosebrough N, Farr A, Fassino G, Vertua R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMed
15.
Polat A, Parlakpinar H, Tasdemir S, Colak C, Vardi N, Ucar M, Emre MH, Acet A (2006) Protective role of aminoguanidine on gentamicin-induced acute renal failure in rats. Acta Histochem 108:365–371PubMedCrossRef
16.
Devasagayam TP, Tarachand U (1987) Decreased lipid peroxidation in the rat kidney during gestation. Biochem Biophys Res Commun 145(1):134–138PubMedCrossRef
17.
Marklund S, Marlund G (1974) Involvement of superoxide anion radical in autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474PubMedCrossRef
18.
Johansson LH, Borg LAH (1988) A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem 174:331–336PubMedCrossRef
19.
Rotruck JT, Pop AL, Ganther H, Hafeman BG, Hoeksira WG (1973) Selenium: biochemical role as a component of glutathione peroxides. Science 179:588–590PubMedCrossRef
20.
Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7136PubMed
21.
Moron MS, DePierre JW, Manerwik KB (1979) Levels of glutathione, glutathione reductase and glutathione-S-transferase acitivities in rat lung and liver. Biochim Biophys Act 582:67–68CrossRef
22.
Omaye ST, Turnbull JD, Sauberlich HE (1979) Selected methods for the determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 62:3–11PubMedCrossRef
23.
Gupta S, Kumar H, Soni J (2005) Effect of Vitamin E and selenium supplementation on concentrations of plasma cortisol and erythrocyte lipid peroxides and the incidence of retained fetal membranes in crossbred dairy cattle. Theriogenology 64(6):1273–1286PubMedCrossRef
24.
Davis L, Kuttan G (2001) Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol 75(2–3):165–168PubMedCrossRef
25.
Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004) Oxidative stress and cell signalling. Curr Med Chem 11(9):1163–1182PubMedCrossRef
26.
Choudhury R, Chowrimootoo G, Srai K, Debnam E, Rice-Evans C (1999) Interactions of the flavonoid naringenin in the gastrointestinal tract and the influence of glycosylation. BiochemBiophys Res Co 265:410–415CrossRef
27.
Cao Hui, Chen Longsheng, Xiao Jianbo (2011) Binding Citrus flavanones to human serum albumin: effect of structure on affinity. Mol Biol Rep 38:2257–2262PubMedCrossRef
28.
Druckrey H, Preussmann R, Ivankovic S, Schmähl D (1967) Organotropic carcinogenic effects of 65 various N-nitroso-compounds on BD rats. Z Krebsforsch 69(2):103–201PubMedCrossRef
29.
Levine JJ, Pettei MJ, Valderrama E, Gold DM, Kessler BH, Trachtman H (1998) Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease. J Pediatr Gastroenterol Nutr 26(1):34–38PubMedCrossRef
30.
Ambs S, Merriam WG, Bennett WP, Felley-Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC (1998) Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 58(2):334–341PubMed
31.
Lake BG, Beamand JA, Tredger JM, Barton PT, Renwick AB, Price RJ (1999) Inhibition of xenobiotic-induced genotoxicity in cultured precision-cut human and rat liver slices. Mutat Res 440:91–100PubMedCrossRef
32.
Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40PubMedCrossRef
33.
34.
Meiyanto E, Hermawan A, Junedi S, Fitriasari A, Susidarti RA (2011) Nobiletin Increased Cytotoxic Activity of Doxorubicin on MCF-7 Cells But Not on T47D Cells. Int J Phytomedicine 3:129–137
35.
Wang DY, Dulbrook RD, Hayward JL, Hendrick JC, Franchimont P (1975) Relationship between plasma CEA and prognosis in women with breast cancer. Eur J Cancer 11:615–625PubMedCrossRef
36.
Mughal AW, Hortobagyi GN, Fritsche HA, Buzdar AU, Yap HY, Blumenschein GR (1983) Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA 249(14):1881–1886PubMedCrossRef
37.
Rogers GT (1983) Carcino embryonic antigen and related glycoproteins—molecular aspects and specificity. Biochim Biophys Acta 1983(695):227–249
38.
Hirano T, Abe K, Gotoh M, Oka K (1995) Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 72(6):1380–1388PubMedCentralPubMedCrossRef
39.
Yao X, Zhu X, Pan S, Fang Y, Jiang F, Phillips GO, Xu X (2012) Antimicrobial activity of nobiletin and tangeretin against pseudomonas. Food Chem 132:1883–1890CrossRef
40.
Mates JM, Perez-Gomez C (1999) Nunez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem 32:595–603PubMedCrossRef
41.
Lee SR, Bar-Noy S, Kwon J, Levine RL, Stadtman TC, Rhee SG (2000) Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 7(6):2521–2526CrossRef
42.
Vecanova J, Hodorova I, Mihalik J, Benicky M, Kluchova D, Rybarova S (2011) Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma. Bratisl Lek Listy 112(2):67–70PubMed
43.
Valderrama B, Ayala M, Vazquez-Duhalt R (2002) Suicide inactivation of peroxidases and the challenge of engineering more robust enzymes. Chem Biol 9:555–565PubMedCrossRef
44.
Heijnen CGM, Haenen GRMM, van Acker FAA, van der Vijgh WJF, Bast A (2001) Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups. Toxicol Invitro 15:3–6
45.
Roomi MW, Roomi NW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M (2005) Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague–Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res 7(3):291–295CrossRef
46.
Nugroho PA, Sukamdi DP, Darma AP, Jenie RI, Meiyanto E (2010) Penelusuran Mekanisme Flavonoid Kulit jeruk keprok (Citrus reticulata) Sebagai Agen Kemopreventif Melalui Docking Molekul pada Protein Target CYP1A2. Farmasains 1:37–44
Metadata
Title
Antitumor efficacy of tangeretin by targeting the oxidative stress mediated on 7,12-dimethylbenz(a) anthracene-induced proliferative breast cancer in Sprague–Dawley rats
Authors
Kuppusamy Periyasamy
Kuppusamy Baskaran
Aruldass Ilakkia
Kalappan Vanitha
Sundaramoorthy Selvaraj
Dhanapal Sakthisekaran
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Cancer Chemotherapy and Pharmacology / Issue 2/2015
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s00280-014-2629-z

Other articles of this Issue 2/2015

Cancer Chemotherapy and Pharmacology 2/2015 Go to the issue

Original Article

Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells

Original Article

Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer

Original Article

Phase II study evaluating efficacy and safety of everolimus with letrozole for management of advanced (unresectable or metastatic) non-small cell lung cancer after failure of platinum-based treatment: a preliminary analysis of toxicity

Short Communication

Novel in silico-designed estradiol analogues are cytotoxic to a multidrug-resistant cell line at nanomolar concentrations

Original Article

A Phase I study of cabazitaxel in patients with advanced gastric cancer who have failed prior chemotherapy (GASTANA)

Original Article

Novel FTS-diamine/cinnamic acid hybrids inhibit tumor cell proliferation and migration and promote apoptosis via blocking Ras-related signaling in vitro
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits